Tenon Medical(R) Announces Issuance of Three U.S. Patents

ACCESSWIRE10-18

Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods LOS GATOS, CA / ACCESSWIRE / October 17, 2024 / ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2476434535?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0zRmSoFnhPFh7_rj99_lZg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/15428fabdb6c2bb0cc631cc63aafe0db","is_english":true,"pubTime":"2024-10-18 04:05","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2476434535","market":"us","top_or_hot":-1,"title":"Tenon Medical(R) Announces Issuance of Three U.S. Patents","media":"ACCESSWIRE","content":"<div>\n<p>Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods\nLOS GATOS, CA / ACCESSWIRE / October 17, 2024 / ...</p>\n\n<a href=\"https://finance.yahoo.com/news/tenon-medical-r-announces-issuance-200500542.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tenon Medical(R) Announces Issuance of Three U.S. Patents</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenon Medical(R) Announces Issuance of Three U.S. Patents\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-18 04:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/tenon-medical-r-announces-issuance-200500542.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods\nLOS GATOS, CA / ACCESSWIRE / October 17, 2024 / ...</p>\n\n<a href=\"https://finance.yahoo.com/news/tenon-medical-r-announces-issuance-200500542.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4232","symbol_name":"货物陆运","start_time":0,"source_url":"https://finance.yahoo.com/news/tenon-medical-r-announces-issuance-200500542.html","article_id":"2476434535","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0zRmSoFnhPFh7_rj99_lZg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/15428fabdb6c2bb0cc631cc63aafe0db"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2476434535","pubTimestamp":1729195500,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods. LOS GATOS, CA / ACCESSWIRE / October 17, 2024 / Tenon Medical, Inc.  , a company transforming care for patients suffering from certain Sacroiliac Joint  disorders, today announced the issuance of U.S. Patent Nos. 12,115,075, 12,115,076 and 12,115,077.U.S. Patent Nos. 12,115,075 and 12,115,076, both entitled \"Sacroiliac Joint Stabilization Prostheses\", are directed to Tenon's enhanced Catamaran prostheses that include unique drug delivery compositions, which enhance sealing of the prostheses in SI joint bone structures and bone growth about and within the prostheses when the prostheses are implanted in a SI joint.U.S. Patent No. 12,115,077, entitled \"Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints\", is directed to SI joint prostheses with unique structures and configurations to correct failed SI joint stabilization with ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4232":"货物陆运","TNONW":"TENON MEDICAL INC","BK4082":"医疗保健设备","SIJ":"ProShares UltraShort Industrials","BK4022":"陆运","R":"瑞德系统","TNON":"Tenon Medical, Inc."},"translate_title":"Tenon Medical(R)宣布授予三项美国专利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"R":1,"SIJ":1,"TNON":1,"TNONW":0.9},"content_text":"Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods\nLOS GATOS, CA / ACCESSWIRE / October 17, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) (\"Tenon\" or the \"Company\"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced the issuance of U.S. Patent Nos. 12,115,075, 12,115,076 and 12,115,077.\nU.S. Patent Nos. 12,115,075 and 12,115,076, both entitled \"Sacroiliac Joint Stabilization Prostheses\", are directed to Tenon's enhanced Catamaran® prostheses that include unique drug delivery compositions, which enhance sealing of the prostheses in SI joint bone structures and bone growth about and within the prostheses when the prostheses are implanted in a SI joint.\nU.S. Patent No. 12,115,077, entitled \"Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints\", is directed to SI joint prostheses with unique structures and configurations to correct failed SI joint stabilization with alternative commercial SI joint implants without requiring removal of the failed implant.\nThe three (3) U.S. patents further enhance the Company's growing patent portfolio for its Catamaran® SI Joint Fusion System, which now comprises twelve (12) issued U.S. and foreign (International) patents, and twenty-three (23) pending U.S. and foreign patent applications.\n\"We are pleased with the USPTO's recognition of the novel Catamaran® SI joint prostheses that will provide a best in class solution to specifically address the need for revision of other ineffective SI joint devices,\" commented Richard Ginn, Co-Founder and Chief Technology Officer of Tenon Medical. He concluded, \"The issuance of these patents reinforces Tenon's focus on innovation while simultaneously protecting our technology platform which strengthens our competitive position in the industry.\"\nAbout Tenon Medical, Inc.\n\nTenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on two commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, and 2) Revision procedures of failed SI Joint implants. For more information, please visit www.tenonmed.com.\nThe Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.\nSafe Harbor\nThis press release contains \"forward-looking statements,\" which are statements related to events, results, activities, or developments that Tenon expects, believes, or anticipates will or may occur in the future. Forward-looking often contains words such as \"intends,\" \"estimates,\" \"anticipates,\" \"hopes,\" \"projects,\" \"plans,\" \"expects,\" \"seek,\" \"believes,\" \"see,\" \"should,\" \"will,\" \"would,\" \"target,\" \"aims,\" and similar expressions and the negative versions thereof. Such statements are based on Tenon's experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances, and speak only as of the date made. Forward-looking statements are inherently uncertain and actual results may differ materially from assumptions, estimates or expectations reflected or contained in the forward-looking statements as a result of various factors. For details on the uncertainties that may cause our actual results to be materially different than those expressed in our forward-looking statements, please review our Annual Report on 10-K on file with the Securities and Exchange Commission at www.sec.gov, particularly the information contained in the section entitled \"Risk Factors\". We undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise unless required by law.\nIR Contact:\nShannon Devine / Rory Rumore203-741-8811MZ North Americatenon@mzgroup.us\nSOURCE: Tenon Medical, Inc.\n\nView the original \npress release on accesswire.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2476434535"}